deltatrials
Completed PHASE4 NCT00000428

Combining N-of-1 Trials to Assess Fibromyalgia Treatments

Combining N-of-1 Trials to Assess Fibromyalgia Therapies

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Conditions Fibromyalgia
Interventions Amitriptyline Amitriptyline plus Fluoxitine
Updated 5 times since 2017 Last updated: Jul 31, 2013 Started: Sep 30, 2000 Primary completion: Mar 31, 2004 Completion: Mar 31, 2004

Listed as NCT00000428, this PHASE4 trial focuses on Fibromyalgia and remains completed. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), it has been updated 5 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Sep 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • Tufts Medical Center
Data source: Tufts Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations